☆ 4.5 Article

Economic analysis of use of counterfeit drugs: health impairment risk of counterfeit phosphodiesterase type 5 inhibitor taken as an example

Environmental Health and Preventive Medicine (2010)

Journal

Environmental Health and Preventive Medicine

Volume 15, Issue 4, Pages 244-251

Publisher

Springer Nature

DOI: 10.1007/s12199-010-0134-5

Keywords

-

Categories

Public, Environmental & Occupational Health

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.